Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CodeLab Capital ASOSL:CODE +5.12%53 Days Sales Outstanding is 33.24 as of Dec. 2025, which is 69% below its 10-year median of 105.96. GuruFocus rates OSL:CODE with a GF Score™ of 53/100 and a GF Value™ of kr2.20 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 662 Healthcare Providers & Services companies, CodeLab Capital AS ranks better than 63.9% on this metric.
The historical rank and industry rank for CodeLab Capital AS's Days Sales Outstanding or its related term are showing as below:
OSL:CODE'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 33.67 Med: 105.96 Max: 260.92
Current: 33.67
During the past 8 years, CodeLab Capital AS's highest Days Sales Outstanding was 260.92. The lowest was 33.67. And the median was 105.96.
OSL:CODE's Days Sales Outstanding is ranked better than 63.9% of 662
companies
in the Healthcare Providers & Services industry
Industry Median: 45.825
vs OSL:CODE: 33.67
CodeLab Capital AS's Days Sales Outstanding
declined
from Dec. 2024 (172.36) to Dec. 2025 (33.24).
CodeLab Capital AS (OSL:CODE) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
CodeLab Capital AS Days Sales Outstanding Related Terms
CodeLab Capital AS Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for CodeLab Capital AS's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSL:CODE vs VEEV, BTSG, HQY: Days Sales Outstanding Comparison
For the Health Information Services subindustry, CodeLab Capital AS's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CodeLab Capital AS Days Sales Outstanding vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, CodeLab Capital AS's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where CodeLab Capital AS's Days Sales Outstanding falls into.
CodeLab Capital AS Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CodeLab Capital AS (OSL:CODE) has a Days Sales Outstanding of 33.24 as of Dec. 2025. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on CodeLab Capital AS and its competitors. This is 69% below median its historical median of 105.96. Over the past decade, CodeLab Capital AS's Days Sales Outstanding has ranged from 33.67 to 260.92. According to the industry distribution chart, CodeLab Capital AS ranks #239 out of 662 companies in the Healthcare Providers & Services industry, placing it in the top 36.1%.
Is CodeLab Capital AS's Days Sales Outstanding too high?
CodeLab Capital AS's current Days Sales Outstanding of 33.24 is 69% below median its 10-year median of 105.96. Over the past 10 years, this metric has ranged from a low of 33.67 to a high of 260.92. The Healthcare Providers & Services industry median Days Sales Outstanding is 45.83. CodeLab Capital AS's value of 33.24 is 27.5% below this industry median. Based on the distribution chart, CodeLab Capital AS ranks #239 out of 662 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, CodeLab Capital AS has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does CodeLab Capital AS's Days Sales Outstanding compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, CodeLab Capital AS ranks #239 out of 662 companies for Days Sales Outstanding. This puts CodeLab Capital AS in the upper half of its industry. The industry median Days Sales Outstanding is 45.83. CodeLab Capital AS's value of 33.24 is 27.5% below this benchmark. Historically, CodeLab Capital AS's own Days Sales Outstanding has ranged from 33.67 to 260.92 over the past decade. While the company's 10-year median is 105.96 vs. the industry median of 45.83, CodeLab Capital AS has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Healthcare Providers & Services company?
The median Days Sales Outstanding among Healthcare Providers & Services companies is 45.83, based on 662 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CodeLab Capital AS's current Days Sales Outstanding of 33.24 is 27.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on CodeLab Capital AS and its competitors. For the Healthcare Providers & Services industry, the median Days Sales Outstanding is 45.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CodeLab Capital AS's current Days Sales Outstanding is 33.24, which is 69% below median its own 10-year median of 105.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CodeLab Capital AS stock overvalued right now?
Based on GuruFocus' analysis, CodeLab Capital AS (OSL:CODE) is currently considered Significantly Overvalued. The stock's GF Value™ is kr2.20, compared to a current price of kr3.90 — trading 77.3% above its estimated fair value. The current Days Sales Outstanding is 33.24, which is 69% below median its 10-year median of 105.96 and 27.5% below the Healthcare Providers & Services industry median of 45.83. CodeLab Capital AS's overall GF Score™ is 53/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For CodeLab Capital AS (OSL:CODE), the current Days Sales Outstanding is 33.24 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CodeLab Capital AS (OSL:CODE) Overvalued in 2026?
Based on GuruFocus' analysis, CodeLab Capital AS stock appears to be overvalued.
The current stock price of kr3.90 is trading 77.3% above its estimated GF Value™ of kr2.20.
GuruFocus considers CodeLab Capital AS to be Significantly Overvalued.
Key valuation signals for OSL:CODE:
Days Sales Outstanding: 33.24 (69% below median its 10-year median of 105.96)
GF Value™: kr2.20 vs. price of kr3.90 (77.3% above fair value)
Industry Position: 27.5% below the Healthcare Providers & Services median (#239 of 662)
No single metric tells the full story. See the OSL:CODE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CodeLab Capital AS builds and invests in next-generation technology. Its primary objective is to invest in other companies and contribute with capital, network, and operations. CodeLab Capital AS is a holding company that, through its subsidiary, is engaged in making software development tools for the broader B2B market.
53GF Score
Get the complete analysis for OSL:CODE
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSL:CODE has been successfully added to your 
